Why should you care? The answer is empathy. When we empathize with others, we make decisions that are greater than ourselves.” ...

PUMCH-GENESIS currently can flag possible rare genetic diseases or complex neurodevelopmental conditions promptly - Anadolu ...

CSL Behring KK has gained approval from Japan's Ministry of Health, Labour and Welfare (MHLW) to manufacture and market ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)[1] and OXB,[2] today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

When symptoms such as "noticing significant developmental delays in mobility, language, and social interaction since age two" ...

Dr Pranav Gupta, Consultant and Head, Molecular Biology Regional Reference Lab at Apollo Diagnostic Delhi, explains, “Genetic ...

为解决结直肠癌（CRC）治疗难题，研究人员开展 MLKL 与 HHT 联合治疗 CRC 的研究。结果发现二者联用可抑制 CRC 细胞自噬、触发 parthanatos 并抑制肿瘤生长。该研究为 CRC 治疗提供新方向，值得科研读者一读。

A visitor tries a surgery robot at the booth of Medtronic at the Medical Equipment & Healthcare Products Exhibition Area ...

Qure's AMT-130 shows 80% Huntington's progress reduction, eyeing FDA approval. Click here to read why I rate QURE stock a Buy ...

Brandi Muhle was 9 years old when her 35-year-old mother, an Omaha police officer and a marathon runner, was first diagnosed ...

A Phase III trial evaluating nex-z in transthyretin amyloidosis with cardiomyopathy is underway, with plans for another ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...